Cardiology

2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome Use of Predicted Risk and Expected Benefit to Guide Decision-Making in Cardiovascular-Kidney-Metabolic Syndrome for the Primary Prevention of Cardiovascular Disease Convergent Hybrid Ablation Versus Catheter Ablation in Patients With Persistent Atrial Fibrillation and Heart Failure: HALT AF Study Protocol and Rationale for a Multicenter Randomized Controlled Trial Longitudinal Echocardiographic Parameters of Diastolic Dysfunction Are Influenced by Kidney Function: A Study in Routine Clinical Practice Paclitaxel Noninferior to Paclitaxel: Registry‐Scale Evidence for an Urea‐Excipient Drug‐Coated Balloon in a Real World Population: A Commentary on the SCAAR Nationwide Comparative Registry Analysis Organ‐Specific Efficacy of Postischemic Empagliflozin in Acute Stroke and Myocardial Infarction Using Preclinical Models Beyond Traditional Risk Factors: The Role of Mental Health and Intersectionality in Cardiovascular Disease Risk Prediction Models Cardiac Biomarkers to Refine Pretest Probability for Coronary Obstruction and Predict Survival After Revascularization in Chronic Coronary Syndrome Fifty Years From the First Framingham Risk Profile: Are We Getting Closer to Identifying and PREVENTing Subclinical Disease Progression? Real‐World Usage of a Paclitaxel‐Coated Balloon With Urea Compared With Other Contemporary Drug‐Coated Balloons: A 2‐Year Analysis From SCAAR in Over 6000 Patients